Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Corcept Therapeutics Inc (HTD.BE)

62.84
+2.64
+(4.39%)
At close: April 25 at 8:08:16 AM GMT+2
Loading Chart for HTD.BE
  • Previous Close 60.20
  • Open 62.84
  • Bid 63.00 x --
  • Ask 63.28 x --
  • Day's Range 62.84 - 62.84
  • 52 Week Range 21.10 - 105.20
  • Volume 0
  • Avg. Volume 7
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: HTD.BE

View More

Performance Overview: HTD.BE

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HTD.BE
26.54%
S&P 500 (^GSPC)
6.06%

1-Year Return

HTD.BE
202.99%
S&P 500 (^GSPC)
9.44%

3-Year Return

HTD.BE
202.70%
S&P 500 (^GSPC)
28.61%

5-Year Return

HTD.BE
446.43%
S&P 500 (^GSPC)
94.77%

Compare To: HTD.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HTD.BE

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    6.68B

  • Enterprise Value

    6.35B

  • Trailing P/E

    57.86

  • Forward P/E

    43.10

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.96

  • Price/Book (mrq)

    11.05

  • Enterprise Value/Revenue

    10.65

  • Enterprise Value/EBITDA

    51.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HTD.BE

View More

Company Insights: HTD.BE

Research Reports: HTD.BE

View More